Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02761720 · ClinicalTrials.gov registry record

Mobile App for Mood in Pregnancy (Ginger iO)

A clinical trial of Depression and Mood Disorders, sponsored by University of Pennsylvania.

Completed
Registry status
72
Enrollment target
1
Study location

NCT02761720: Completed study of Depression and Mood Disorders, sponsored by University of Pennsylvania.

NCT02761720 is a study of Depression and Mood Disorders that has completed, run by University of Pennsylvania. The registered enrollment target is 72 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add start date to calendar (.ics) →

The verdict

NCT02761720, a study of Depression and Mood Disorders, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
72 participants
Enrollment target
1
Study location

Study Summary

The Mobile Mood Tracking App study is a small randomized trial of acceptability and usability of a mobile phone mood tracking application (mobile app) among women with depressed mood in pregnancy. The study will be assessing the perceived value and usability of this tool in pregnancy over eight weeks to test whether women using this app are more likely to receive assessments and treatments of depressed mood than women not using it.

Interventions

  • OTHER No Intervention

Study Locations (1)

Pennsylvania

  • Dickens Center for Women's Health at the Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2015-02
University of Pennsylvania

1,423 total trials

What the finished NCT02761720 record still lists

NCT02761720 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.

NCT02761720 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02761720 about?

NCT02761720 is a clinical study titled "Mobile App for Mood in Pregnancy (Ginger iO)". The Mobile Mood Tracking App study is a small randomized trial of acceptability and usability of a mobile phone mood tracking application (mobile app) among women with depressed mood in pregnancy. The study will be assessing the perceived value and usability of this tool in pregnancy over eight week...

What is the current status of trial NCT02761720?

This trial is currently completed. The enrollment target is 72 participants. The study started on 2015-02.

What conditions does trial NCT02761720 study?

This clinical trial studies the following conditions: Depression, Mood Disorders.

What interventions are being tested in trial NCT02761720?

The interventions under investigation include: No Intervention (OTHER).

Who is sponsoring clinical trial NCT02761720?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02761720 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02761720's enrollment target sits among peer trials

72 402nd of 679 higher than 277 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02761720, the US trial registry maintained by the National Library of Medicine. NCT02761720 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.